These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 24673719

  • 1. Antitumor effect of fibrin glue containing temozolomide against malignant glioma.
    Anai S, Hide T, Takezaki T, Kuroda J, Shinojima N, Makino K, Nakamura H, Yano S, Kuratsu J.
    Cancer Sci; 2014 May; 105(5):583-91. PubMed ID: 24673719
    [Abstract] [Full Text] [Related]

  • 2. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth.
    Dong J, Zhou G, Tang D, Chen Y, Cui B, Dai X, Zhang J, Lan Q, Huang Q.
    J Cancer Res Clin Oncol; 2012 Dec; 138(12):2079-84. PubMed ID: 22825126
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death.
    Cheng Y, Sk UH, Zhang Y, Ren X, Zhang L, Huber-Keener KJ, Sun YW, Liao J, Amin S, Sharma AK, Yang JM.
    PLoS One; 2012 Dec; 7(4):e35104. PubMed ID: 22496897
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Liu Z, Jiang X, Gao L, Liu X, Li J, Huang X, Zeng T.
    World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells.
    Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S.
    Cell Death Differ; 2004 Apr; 11(4):448-57. PubMed ID: 14713959
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Carnosic acid potentiates the anticancer effect of temozolomide by inducing apoptosis and autophagy in glioma.
    Shao N, Mao J, Xue L, Wang R, Zhi F, Lan Q.
    J Neurooncol; 2019 Jan; 141(2):277-288. PubMed ID: 30460630
    [Abstract] [Full Text] [Related]

  • 14. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression.
    Jiang C, Shen F, Du J, Fang X, Li X, Su J, Wang X, Huang X, Liu Z.
    Biomed Pharmacother; 2018 Jan; 97():844-850. PubMed ID: 29136760
    [Abstract] [Full Text] [Related]

  • 15. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z, Xie G, Zhou G, Cheng Y, Zhang G, Yao G, Chen Y, Li Y, Zhao G.
    Cancer Lett; 2015 Oct 10; 367(1):58-68. PubMed ID: 26188279
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways.
    Sun S, Lee D, Ho AS, Pu JK, Zhang XQ, Lee NP, Day PJ, Lui WM, Fung CF, Leung GK.
    Neuro Oncol; 2013 May 10; 15(5):562-77. PubMed ID: 23444257
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A combined preclinical therapy of cannabinoids and temozolomide against glioma.
    Torres S, Lorente M, Rodríguez-Fornés F, Hernández-Tiedra S, Salazar M, García-Taboada E, Barcia J, Guzmán M, Velasco G.
    Mol Cancer Ther; 2011 Jan 10; 10(1):90-103. PubMed ID: 21220494
    [Abstract] [Full Text] [Related]

  • 19. Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model.
    Ningaraj NS, Sankpal UT, Khaitan D, Meister EA, Vats TS.
    Cancer Biol Ther; 2009 Oct 10; 8(20):1924-33. PubMed ID: 19738431
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.